The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.

Jones G. G., Del Rio I. B., Sari S., Sekerim A., Young L. C., Hartig N., ...More

AACR Special Conference on Targeting RAS-Driven Cancers, California, United States Of America, 9 - 12 December 2018, vol.18, pp.65-66 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 18
  • City: California
  • Country: United States Of America
  • Page Numbers: pp.65-66
  • Abdullah Gül University Affiliated: No